nodes	percent_of_prediction	percent_of_DWPC	metapath
Celecoxib—hematologic cancer—Methylprednisolone—allergic rhinitis	0.147	0.245	CpDpCtD
Celecoxib—kidney cancer—Hydrocortisone—allergic rhinitis	0.0783	0.131	CpDpCtD
Celecoxib—colon cancer—Betamethasone—allergic rhinitis	0.0661	0.111	CpDpCtD
Celecoxib—colon cancer—Dexamethasone—allergic rhinitis	0.0661	0.111	CpDpCtD
Celecoxib—prostate cancer—Hydrocortisone—allergic rhinitis	0.0566	0.0947	CpDpCtD
Celecoxib—kidney cancer—Betamethasone—allergic rhinitis	0.0478	0.0799	CpDpCtD
Celecoxib—kidney cancer—Dexamethasone—allergic rhinitis	0.0478	0.0799	CpDpCtD
Celecoxib—prostate cancer—Dexamethasone—allergic rhinitis	0.0346	0.0578	CpDpCtD
Celecoxib—prostate cancer—Betamethasone—allergic rhinitis	0.0346	0.0578	CpDpCtD
Celecoxib—PTGS2—Triamcinolone—allergic rhinitis	0.0241	0.108	CbGbCtD
Celecoxib—PTGS2—Betamethasone—allergic rhinitis	0.0206	0.0925	CbGbCtD
Celecoxib—CYP2C9—Desloratadine—allergic rhinitis	0.0205	0.0921	CbGbCtD
Celecoxib—osteoarthritis—Methylprednisolone—allergic rhinitis	0.0195	0.0325	CpDpCtD
Celecoxib—CYP2D6—Desloratadine—allergic rhinitis	0.0188	0.0842	CbGbCtD
Celecoxib—PTGS2—Dexamethasone—allergic rhinitis	0.012	0.0538	CbGbCtD
Celecoxib—CYP3A4—Flunisolide—allergic rhinitis	0.0119	0.0536	CbGbCtD
Celecoxib—CYP2C9—Montelukast—allergic rhinitis	0.0118	0.0529	CbGbCtD
Celecoxib—CYP2C9—Loratadine—allergic rhinitis	0.0118	0.0529	CbGbCtD
Celecoxib—CYP2C9—Diphenhydramine—allergic rhinitis	0.0118	0.0529	CbGbCtD
Celecoxib—CYP3A4—Olopatadine—allergic rhinitis	0.0112	0.0503	CbGbCtD
Celecoxib—CYP2D6—Loratadine—allergic rhinitis	0.0108	0.0484	CbGbCtD
Celecoxib—CYP2D6—Diphenhydramine—allergic rhinitis	0.0108	0.0484	CbGbCtD
Celecoxib—CYP3A4—Montelukast—allergic rhinitis	0.00686	0.0308	CbGbCtD
Celecoxib—CYP3A4—Loratadine—allergic rhinitis	0.00686	0.0308	CbGbCtD
Celecoxib—CYP3A4—Methylprednisolone—allergic rhinitis	0.00627	0.0281	CbGbCtD
Celecoxib—CYP3A4—Triamcinolone—allergic rhinitis	0.00475	0.0213	CbGbCtD
Celecoxib—CA6—saliva—allergic rhinitis	0.00467	0.15	CbGeAlD
Celecoxib—CA6—ear—allergic rhinitis	0.00427	0.137	CbGeAlD
Celecoxib—CYP2C9—Dexamethasone—allergic rhinitis	0.00408	0.0183	CbGbCtD
Celecoxib—CYP3A4—Betamethasone—allergic rhinitis	0.00408	0.0183	CbGbCtD
Celecoxib—CYP3A4—Prednisolone—allergic rhinitis	0.00402	0.018	CbGbCtD
Celecoxib—CYP3A4—Hydrocortisone—allergic rhinitis	0.00381	0.0171	CbGbCtD
Celecoxib—CYP2D6—Dexamethasone—allergic rhinitis	0.00373	0.0167	CbGbCtD
Celecoxib—ORM1—saliva—allergic rhinitis	0.00249	0.0797	CbGeAlD
Celecoxib—CYP3A4—Dexamethasone—allergic rhinitis	0.00237	0.0106	CbGbCtD
Celecoxib—CA6—exocrine gland—allergic rhinitis	0.00236	0.0757	CbGeAlD
Celecoxib—PDPK1—respiratory system—allergic rhinitis	0.00203	0.0652	CbGeAlD
Celecoxib—MAPK14—respiratory system—allergic rhinitis	0.00109	0.0349	CbGeAlD
Celecoxib—PDPK1—lung—allergic rhinitis	0.00108	0.0346	CbGeAlD
Celecoxib—MAPK14—TSLP Signaling Pathway—TSLP—allergic rhinitis	0.000917	0.0476	CbGpPWpGaD
Celecoxib—MAPK14—epithelium—allergic rhinitis	0.000908	0.0291	CbGeAlD
Celecoxib—MAPK14—bronchus—allergic rhinitis	0.000895	0.0287	CbGeAlD
Celecoxib—MAPK14—skin of body—allergic rhinitis	0.000864	0.0277	CbGeAlD
Celecoxib—CA12—respiratory system—allergic rhinitis	0.000825	0.0264	CbGeAlD
Celecoxib—CA2—exocrine gland—allergic rhinitis	0.000813	0.0261	CbGeAlD
Celecoxib—PDPK1—CXCR3-mediated signaling events—CCL11—allergic rhinitis	0.000774	0.0402	CbGpPWpGaD
Celecoxib—CA12—eye—allergic rhinitis	0.000753	0.0242	CbGeAlD
Celecoxib—CA12—trachea—allergic rhinitis	0.000609	0.0195	CbGeAlD
Celecoxib—MAPK14—lung—allergic rhinitis	0.000577	0.0185	CbGeAlD
Celecoxib—CA4—respiratory system—allergic rhinitis	0.000511	0.0164	CbGeAlD
Celecoxib—ABCC4—bronchus—allergic rhinitis	0.000457	0.0147	CbGeAlD
Celecoxib—CA12—lung—allergic rhinitis	0.000438	0.014	CbGeAlD
Celecoxib—PDPK1—G beta:gamma signalling through PI3Kgamma—IL5—allergic rhinitis	0.000434	0.0225	CbGpPWpGaD
Celecoxib—PDPK1—GPVI-mediated activation cascade—IL5—allergic rhinitis	0.000427	0.0221	CbGpPWpGaD
Celecoxib—CA2—respiratory system—allergic rhinitis	0.000423	0.0136	CbGeAlD
Celecoxib—PTGS2—Fluocinonide—Flunisolide—allergic rhinitis	0.000422	0.213	CbGdCrCtD
Celecoxib—PDPK1—G-protein beta:gamma signalling—IL5—allergic rhinitis	0.000413	0.0214	CbGpPWpGaD
Celecoxib—MAPK14—CXCR3-mediated signaling events—CCL11—allergic rhinitis	0.000402	0.0209	CbGpPWpGaD
Celecoxib—CA5B—lung—allergic rhinitis	0.000393	0.0126	CbGeAlD
Celecoxib—CA2—eye—allergic rhinitis	0.000387	0.0124	CbGeAlD
Celecoxib—PDPK1—Downstream TCR signaling—HLA-DQB1—allergic rhinitis	0.000381	0.0198	CbGpPWpGaD
Celecoxib—CA4—trachea—allergic rhinitis	0.000377	0.0121	CbGeAlD
Celecoxib—CA2—epithelium—allergic rhinitis	0.000354	0.0113	CbGeAlD
Celecoxib—PDPK1—Fc epsilon receptor (FCERI) signaling—MS4A2—allergic rhinitis	0.000351	0.0182	CbGpPWpGaD
Celecoxib—CA2—bronchus—allergic rhinitis	0.000348	0.0112	CbGeAlD
Celecoxib—ORM1—lung—allergic rhinitis	0.000347	0.0111	CbGeAlD
Celecoxib—MAPK14—TSLP Signaling Pathway—CCL11—allergic rhinitis	0.000339	0.0176	CbGpPWpGaD
Celecoxib—CA2—skin of body—allergic rhinitis	0.000337	0.0108	CbGeAlD
Celecoxib—CA2—trachea—allergic rhinitis	0.000313	0.01	CbGeAlD
Celecoxib—PTGS2—respiratory system—allergic rhinitis	0.000313	0.01	CbGeAlD
Celecoxib—ABCC4—lung—allergic rhinitis	0.000295	0.00946	CbGeAlD
Celecoxib—PDPK1—TGF-beta receptor signaling—SMAD3—allergic rhinitis	0.000286	0.0149	CbGpPWpGaD
Celecoxib—PDPK1—TCR signaling—HLA-DQB1—allergic rhinitis	0.000285	0.0148	CbGpPWpGaD
Celecoxib—PDPK1—TCR Signaling Pathway—IL17A—allergic rhinitis	0.000282	0.0146	CbGpPWpGaD
Celecoxib—PDPK1—FCERI mediated NF-kB activation—NFKB1—allergic rhinitis	0.00028	0.0145	CbGpPWpGaD
Celecoxib—MAPK14—Endothelins—CYSLTR1—allergic rhinitis	0.000278	0.0144	CbGpPWpGaD
Celecoxib—MAPK14—IL4-mediated signaling events—CCL11—allergic rhinitis	0.000272	0.0141	CbGpPWpGaD
Celecoxib—CA4—lung—allergic rhinitis	0.000271	0.00869	CbGeAlD
Celecoxib—PDPK1—Interleukin-11 Signaling Pathway—ICAM1—allergic rhinitis	0.000263	0.0136	CbGpPWpGaD
Celecoxib—PTGS2—epithelium—allergic rhinitis	0.000261	0.00838	CbGeAlD
Celecoxib—PTGS2—bronchus—allergic rhinitis	0.000257	0.00825	CbGeAlD
Celecoxib—PTGS2—Fluticasone Propionate—Flunisolide—allergic rhinitis	0.000254	0.129	CbGdCrCtD
Celecoxib—PDPK1—Costimulation by the CD28 family—HLA-DQB1—allergic rhinitis	0.000254	0.0132	CbGpPWpGaD
Celecoxib—PTGS2—skin of body—allergic rhinitis	0.000248	0.00797	CbGeAlD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—TLR1—allergic rhinitis	0.000231	0.012	CbGpPWpGaD
Celecoxib—PTGS2—trachea—allergic rhinitis	0.000231	0.00741	CbGeAlD
Celecoxib—CA2—lung—allergic rhinitis	0.000225	0.00721	CbGeAlD
Celecoxib—MAPK14—Atypical NF-kappaB pathway—NFKB1—allergic rhinitis	0.000216	0.0112	CbGpPWpGaD
Celecoxib—PTGS2—Fluocinonide—Methylprednisolone—allergic rhinitis	0.000206	0.104	CbGdCrCtD
Celecoxib—PDPK1—Downstream TCR signaling—CD4—allergic rhinitis	0.000204	0.0106	CbGpPWpGaD
Celecoxib—CA9—HIF-1-alpha transcription factor network—SMAD3—allergic rhinitis	0.000204	0.0106	CbGpPWpGaD
Celecoxib—PTGS2—Fluocinonide—Betamethasone—allergic rhinitis	0.000203	0.103	CbGdCrCtD
Celecoxib—PTGS2—Fluocinonide—Dexamethasone—allergic rhinitis	0.000203	0.103	CbGdCrCtD
Celecoxib—MAPK14—CD40/CD40L signaling—IL4—allergic rhinitis	0.000202	0.0105	CbGpPWpGaD
Celecoxib—PTGS2—Fluocinonide—Triamcinolone—allergic rhinitis	0.000198	0.1	CbGdCrCtD
Celecoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—allergic rhinitis	0.00019	0.00988	CbGpPWpGaD
Celecoxib—MAPK14—IL4-mediated signaling events—IL5—allergic rhinitis	0.000184	0.00953	CbGpPWpGaD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—TLR1—allergic rhinitis	0.00018	0.00935	CbGpPWpGaD
Celecoxib—PDPK1—Downstream TCR signaling—NFKB1—allergic rhinitis	0.000176	0.00913	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—IL13—allergic rhinitis	0.000172	0.0089	CbGpPWpGaD
Celecoxib—PTGS2—lung—allergic rhinitis	0.000166	0.00532	CbGeAlD
Celecoxib—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—allergic rhinitis	0.000153	0.00795	CbGpPWpGaD
Celecoxib—PDPK1—TCR signaling—CD4—allergic rhinitis	0.000153	0.00792	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—IL5—allergic rhinitis	0.000147	0.00762	CbGpPWpGaD
Celecoxib—MAPK14—TCR Signaling Pathway—IL17A—allergic rhinitis	0.000147	0.00761	CbGpPWpGaD
Celecoxib—MAPK14—IL-4 Signaling Pathway—IL4—allergic rhinitis	0.000146	0.00757	CbGpPWpGaD
Celecoxib—MAPK14—Estrogen signaling pathway—NFKB1—allergic rhinitis	0.000145	0.00754	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—PFN2—allergic rhinitis	0.00014	0.00724	CbGpPWpGaD
Celecoxib—PDPK1—TCR signaling in naïve CD4+ T cells—CD4—allergic rhinitis	0.00014	0.00724	CbGpPWpGaD
Celecoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—allergic rhinitis	0.000139	0.00723	CbGpPWpGaD
Celecoxib—PDPK1—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	0.000139	0.00722	CbGpPWpGaD
Celecoxib—PDPK1—Interleukin-11 Signaling Pathway—TGFB1—allergic rhinitis	0.000139	0.00719	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—FOXP3—allergic rhinitis	0.000137	0.00711	CbGpPWpGaD
Celecoxib—PDPK1—Costimulation by the CD28 family—CD4—allergic rhinitis	0.000136	0.00707	CbGpPWpGaD
Celecoxib—PDPK1—Innate Immune System—MS4A2—allergic rhinitis	0.000136	0.00707	CbGpPWpGaD
Celecoxib—MAPK14—IL4-mediated signaling events—IL10—allergic rhinitis	0.000134	0.00697	CbGpPWpGaD
Celecoxib—MAPK14—IL12-mediated signaling events—IL4—allergic rhinitis	0.000134	0.00696	CbGpPWpGaD
Celecoxib—PDPK1—TCR signaling—NFKB1—allergic rhinitis	0.000132	0.00682	CbGpPWpGaD
Celecoxib—MAPK14—IL4-mediated signaling events—IL4—allergic rhinitis	0.000131	0.00678	CbGpPWpGaD
Celecoxib—PDPK1—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	0.000128	0.00663	CbGpPWpGaD
Celecoxib—PTGS2—Fluticasone Propionate—Methylprednisolone—allergic rhinitis	0.000125	0.063	CbGdCrCtD
Celecoxib—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—allergic rhinitis	0.000124	0.00644	CbGpPWpGaD
Celecoxib—MAPK14—AGE/RAGE pathway—SMAD3—allergic rhinitis	0.000123	0.00638	CbGpPWpGaD
Celecoxib—PTGS2—Fluticasone Propionate—Dexamethasone—allergic rhinitis	0.000123	0.062	CbGdCrCtD
Celecoxib—PTGS2—Fluticasone Propionate—Betamethasone—allergic rhinitis	0.000123	0.062	CbGdCrCtD
Celecoxib—PDPK1—TGF-beta receptor signaling—TGFB1—allergic rhinitis	0.000121	0.00629	CbGpPWpGaD
Celecoxib—PTGS2—Fluticasone Propionate—Triamcinolone—allergic rhinitis	0.00012	0.0606	CbGdCrCtD
Celecoxib—PDPK1—BCR signaling pathway—NFKB1—allergic rhinitis	0.000119	0.00616	CbGpPWpGaD
Celecoxib—MAPK14—Oxidative Stress—NFKB1—allergic rhinitis	0.000117	0.00609	CbGpPWpGaD
Celecoxib—PDPK1—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	0.000116	0.00601	CbGpPWpGaD
Celecoxib—PDPK1—CXCR4-mediated signaling events—CD4—allergic rhinitis	0.000115	0.00597	CbGpPWpGaD
Celecoxib—MAPK14—RANKL/RANK Signaling Pathway—ICAM1—allergic rhinitis	0.000114	0.00593	CbGpPWpGaD
Celecoxib—MAPK14—Thromboxane A2 receptor signaling—ICAM1—allergic rhinitis	0.000113	0.00584	CbGpPWpGaD
Celecoxib—MAPK14—EPO signaling pathway—NFKB1—allergic rhinitis	0.000112	0.00579	CbGpPWpGaD
Celecoxib—PDPK1—TCR Signaling Pathway—CD4—allergic rhinitis	0.000109	0.00565	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—IL4—allergic rhinitis	0.000104	0.00542	CbGpPWpGaD
Celecoxib—MAPK14—CD40/CD40L signaling—NFKB1—allergic rhinitis	0.000102	0.00527	CbGpPWpGaD
Celecoxib—PDPK1—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	9.92e-05	0.00514	CbGpPWpGaD
Celecoxib—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—allergic rhinitis	9.92e-05	0.00514	CbGpPWpGaD
Celecoxib—PDPK1—TCR Signaling Pathway—NFKB1—allergic rhinitis	9.39e-05	0.00487	CbGpPWpGaD
Celecoxib—MAPK14—TWEAK Signaling Pathway—NFKB1—allergic rhinitis	8.98e-05	0.00465	CbGpPWpGaD
Celecoxib—PDPK1—B Cell Receptor Signaling Pathway—NFKB1—allergic rhinitis	8.84e-05	0.00459	CbGpPWpGaD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—SMAD3—allergic rhinitis	8.48e-05	0.0044	CbGpPWpGaD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—ICAM1—allergic rhinitis	8.3e-05	0.0043	CbGpPWpGaD
Celecoxib—PDPK1—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	8.26e-05	0.00429	CbGpPWpGaD
Celecoxib—MAPK14—TSLP Signaling Pathway—NFKB1—allergic rhinitis	8.2e-05	0.00425	CbGpPWpGaD
Celecoxib—MAPK14—Structural Pathway of Interleukin 1 (IL-1)—NFKB1—allergic rhinitis	8.2e-05	0.00425	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—PTGDR2—allergic rhinitis	8.14e-05	0.00422	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—MS4A2—allergic rhinitis	7.94e-05	0.00412	CbGpPWpGaD
Celecoxib—MAPK14—IL12-mediated signaling events—CD4—allergic rhinitis	7.83e-05	0.00406	CbGpPWpGaD
Celecoxib—PDPK1—TCR Signaling Pathway—TGFB1—allergic rhinitis	7.82e-05	0.00406	CbGpPWpGaD
Celecoxib—MAPK14—Angiopoietin receptor Tie2-mediated signaling—NFKB1—allergic rhinitis	7.81e-05	0.00405	CbGpPWpGaD
Celecoxib—MAPK14—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NFKB1—allergic rhinitis	7.81e-05	0.00405	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	7.59e-05	0.00394	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—PTGDR2—allergic rhinitis	7.39e-05	0.00383	CbGpPWpGaD
Celecoxib—MAPK14—IL-4 Signaling Pathway—NFKB1—allergic rhinitis	7.34e-05	0.00381	CbGpPWpGaD
Celecoxib—MAPK14—IL-1 signaling pathway—NFKB1—allergic rhinitis	7.23e-05	0.00375	CbGpPWpGaD
Celecoxib—MAPK14—RANKL/RANK Signaling Pathway—NFKB1—allergic rhinitis	7.23e-05	0.00375	CbGpPWpGaD
Celecoxib—MAPK14—Cardiac Hypertrophic Response—NFKB1—allergic rhinitis	7.23e-05	0.00375	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—MS4A2—allergic rhinitis	7.09e-05	0.00367	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HLA-G—allergic rhinitis	7.07e-05	0.00367	CbGpPWpGaD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—SMAD3—allergic rhinitis	7.07e-05	0.00366	CbGpPWpGaD
Celecoxib—MAPK14—IL12-mediated signaling events—NFKB1—allergic rhinitis	6.75e-05	0.0035	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	6.65e-05	0.00345	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—IL5—allergic rhinitis	6.59e-05	0.00342	CbGpPWpGaD
Celecoxib—PDPK1—BDNF signaling pathway—NFKB1—allergic rhinitis	6.45e-05	0.00334	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—IL4—allergic rhinitis	6.43e-05	0.00333	CbGpPWpGaD
Celecoxib—PDPK1—GPCR downstream signaling—CYSLTR1—allergic rhinitis	6.39e-05	0.00331	CbGpPWpGaD
Celecoxib—MAPK14—Oncostatin M Signaling Pathway—NFKB1—allergic rhinitis	6.33e-05	0.00328	CbGpPWpGaD
Celecoxib—ALB—Vitamin B12 Metabolism—ICAM1—allergic rhinitis	6.27e-05	0.00325	CbGpPWpGaD
Celecoxib—MAPK14—AGE/RAGE pathway—NFKB1—allergic rhinitis	6.25e-05	0.00324	CbGpPWpGaD
Celecoxib—MAPK14—Cardiac Progenitor Differentiation—TGFB1—allergic rhinitis	6.21e-05	0.00322	CbGpPWpGaD
Celecoxib—MAPK14—BCR signaling pathway—NFKB1—allergic rhinitis	6.18e-05	0.0032	CbGpPWpGaD
Celecoxib—MAPK14—Rac1/Pak1/p38/MMP-2 pathway—NFKB1—allergic rhinitis	6.18e-05	0.0032	CbGpPWpGaD
Celecoxib—MAPK14—Cardiac Hypertrophic Response—TGFB1—allergic rhinitis	6.03e-05	0.00313	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CYSLTR1—allergic rhinitis	5.8e-05	0.00301	CbGpPWpGaD
Celecoxib—PDPK1—Downstream signaling events of B Cell Receptor (BCR)—NFKB1—allergic rhinitis	5.73e-05	0.00297	CbGpPWpGaD
Celecoxib—MAPK14—TCR Signaling Pathway—CD4—allergic rhinitis	5.66e-05	0.00294	CbGpPWpGaD
Celecoxib—MAPK14—TRAF6 Mediated Induction of proinflammatory cytokines—NFKB1—allergic rhinitis	5.64e-05	0.00293	CbGpPWpGaD
Celecoxib—MAPK14—Leptin signaling pathway—NFKB1—allergic rhinitis	5.64e-05	0.00293	CbGpPWpGaD
Celecoxib—PDPK1—Signaling by GPCR—CCL11—allergic rhinitis	5.6e-05	0.0029	CbGpPWpGaD
Celecoxib—PDPK1—Fc epsilon receptor (FCERI) signaling—NFKB1—allergic rhinitis	5.47e-05	0.00283	CbGpPWpGaD
Celecoxib—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—allergic rhinitis	5.33e-05	0.00276	CbGpPWpGaD
Celecoxib—Hallucination—Methylprednisolone—allergic rhinitis	5.29e-05	0.000419	CcSEcCtD
Celecoxib—Pharyngitis—Triamcinolone—allergic rhinitis	5.29e-05	0.000419	CcSEcCtD
Celecoxib—Eye disorder—Hydrocortisone—allergic rhinitis	5.29e-05	0.000419	CcSEcCtD
Celecoxib—Myocardial infarction—Dexamethasone—allergic rhinitis	5.28e-05	0.000418	CcSEcCtD
Celecoxib—Myocardial infarction—Betamethasone—allergic rhinitis	5.28e-05	0.000418	CcSEcCtD
Celecoxib—Neuropathy peripheral—Betamethasone—allergic rhinitis	5.28e-05	0.000418	CcSEcCtD
Celecoxib—Neuropathy peripheral—Dexamethasone—allergic rhinitis	5.28e-05	0.000418	CcSEcCtD
Celecoxib—Nausea—Cetirizine—allergic rhinitis	5.28e-05	0.000417	CcSEcCtD
Celecoxib—Pruritus—Montelukast—allergic rhinitis	5.27e-05	0.000417	CcSEcCtD
Celecoxib—MAPK14—Glucocorticoid receptor regulatory network—NFKB1—allergic rhinitis	5.26e-05	0.00273	CbGpPWpGaD
Celecoxib—Conjunctivitis—Dexamethasone—allergic rhinitis	5.24e-05	0.000414	CcSEcCtD
Celecoxib—Conjunctivitis—Betamethasone—allergic rhinitis	5.24e-05	0.000414	CcSEcCtD
Celecoxib—Connective tissue disorder—Methylprednisolone—allergic rhinitis	5.23e-05	0.000413	CcSEcCtD
Celecoxib—Nausea—Flunisolide—allergic rhinitis	5.19e-05	0.00041	CcSEcCtD
Celecoxib—Arrhythmia—Prednisolone—allergic rhinitis	5.18e-05	0.00041	CcSEcCtD
Celecoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—allergic rhinitis	5.16e-05	0.00267	CbGpPWpGaD
Celecoxib—CYP2D6—Melatonin metabolism and effects—NFKB1—allergic rhinitis	5.15e-05	0.00267	CbGpPWpGaD
Celecoxib—Immune system disorder—Hydrocortisone—allergic rhinitis	5.11e-05	0.000404	CcSEcCtD
Celecoxib—MAPK14—MyD88 cascade initiated on plasma membrane—NFKB1—allergic rhinitis	5.11e-05	0.00265	CbGpPWpGaD
Celecoxib—ALB—Folate Metabolism—ICAM1—allergic rhinitis	5.1e-05	0.00265	CbGpPWpGaD
Celecoxib—ABCC4—Platelet degranulation—TGFB1—allergic rhinitis	5.1e-05	0.00264	CbGpPWpGaD
Celecoxib—Diarrhoea—Montelukast—allergic rhinitis	5.1e-05	0.000403	CcSEcCtD
Celecoxib—MAPK14—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—NFKB1—allergic rhinitis	5.06e-05	0.00262	CbGpPWpGaD
Celecoxib—PDPK1—B Cell Activation—NFKB1—allergic rhinitis	5.06e-05	0.00262	CbGpPWpGaD
Celecoxib—Arrhythmia—Hydrocortisone—allergic rhinitis	5.06e-05	0.0004	CcSEcCtD
Celecoxib—PTGS2—Selenium Micronutrient Network—ICAM1—allergic rhinitis	5.01e-05	0.0026	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—IL4—allergic rhinitis	4.99e-05	0.00259	CbGpPWpGaD
Celecoxib—Eye disorder—Methylprednisolone—allergic rhinitis	4.97e-05	0.000393	CcSEcCtD
Celecoxib—MAPK14—MyD88 dependent cascade initiated on endosome—NFKB1—allergic rhinitis	4.97e-05	0.00258	CbGpPWpGaD
Celecoxib—Mental disorder—Hydrocortisone—allergic rhinitis	4.96e-05	0.000392	CcSEcCtD
Celecoxib—Cardiac disorder—Methylprednisolone—allergic rhinitis	4.94e-05	0.00039	CcSEcCtD
Celecoxib—Dizziness—Montelukast—allergic rhinitis	4.92e-05	0.00039	CcSEcCtD
Celecoxib—MAPK14—TCR Signaling Pathway—NFKB1—allergic rhinitis	4.88e-05	0.00253	CbGpPWpGaD
Celecoxib—Haemoglobin—Dexamethasone—allergic rhinitis	4.86e-05	0.000385	CcSEcCtD
Celecoxib—Haemoglobin—Betamethasone—allergic rhinitis	4.86e-05	0.000385	CcSEcCtD
Celecoxib—ABCC4—Response to elevated platelet cytosolic Ca2+—TGFB1—allergic rhinitis	4.86e-05	0.00252	CbGpPWpGaD
Celecoxib—Haemorrhage—Dexamethasone—allergic rhinitis	4.84e-05	0.000383	CcSEcCtD
Celecoxib—Haemorrhage—Betamethasone—allergic rhinitis	4.84e-05	0.000383	CcSEcCtD
Celecoxib—Angiopathy—Methylprednisolone—allergic rhinitis	4.83e-05	0.000382	CcSEcCtD
Celecoxib—Hallucination—Betamethasone—allergic rhinitis	4.81e-05	0.000381	CcSEcCtD
Celecoxib—Hallucination—Dexamethasone—allergic rhinitis	4.81e-05	0.000381	CcSEcCtD
Celecoxib—Immune system disorder—Methylprednisolone—allergic rhinitis	4.8e-05	0.00038	CcSEcCtD
Celecoxib—MAPK14—Toll Like Receptor 9 (TLR9) Cascade—NFKB1—allergic rhinitis	4.79e-05	0.00249	CbGpPWpGaD
Celecoxib—MAPK14—Corticotropin-releasing hormone—NFKB1—allergic rhinitis	4.79e-05	0.00249	CbGpPWpGaD
Celecoxib—Mediastinal disorder—Methylprednisolone—allergic rhinitis	4.79e-05	0.000379	CcSEcCtD
Celecoxib—Arrhythmia—Triamcinolone—allergic rhinitis	4.76e-05	0.000377	CcSEcCtD
Celecoxib—Vision blurred—Prednisolone—allergic rhinitis	4.76e-05	0.000376	CcSEcCtD
Celecoxib—Arrhythmia—Methylprednisolone—allergic rhinitis	4.75e-05	0.000376	CcSEcCtD
Celecoxib—Vomiting—Montelukast—allergic rhinitis	4.74e-05	0.000375	CcSEcCtD
Celecoxib—MAPK14—MyD88:Mal cascade initiated on plasma membrane—NFKB1—allergic rhinitis	4.71e-05	0.00244	CbGpPWpGaD
Celecoxib—Rash—Montelukast—allergic rhinitis	4.7e-05	0.000371	CcSEcCtD
Celecoxib—Dermatitis—Montelukast—allergic rhinitis	4.69e-05	0.000371	CcSEcCtD
Celecoxib—Headache—Montelukast—allergic rhinitis	4.67e-05	0.000369	CcSEcCtD
Celecoxib—Mental disorder—Methylprednisolone—allergic rhinitis	4.66e-05	0.000369	CcSEcCtD
Celecoxib—Angioedema—Prednisolone—allergic rhinitis	4.61e-05	0.000365	CcSEcCtD
Celecoxib—MAPK14—B Cell Receptor Signaling Pathway—NFKB1—allergic rhinitis	4.6e-05	0.00238	CbGpPWpGaD
Celecoxib—Dysgeusia—Triamcinolone—allergic rhinitis	4.54e-05	0.000359	CcSEcCtD
Celecoxib—Vertigo—Prednisolone—allergic rhinitis	4.53e-05	0.000359	CcSEcCtD
Celecoxib—Syncope—Prednisolone—allergic rhinitis	4.52e-05	0.000358	CcSEcCtD
Celecoxib—MAPK14—MyD88-independent cascade—NFKB1—allergic rhinitis	4.52e-05	0.00234	CbGpPWpGaD
Celecoxib—Eye disorder—Dexamethasone—allergic rhinitis	4.52e-05	0.000358	CcSEcCtD
Celecoxib—Eye disorder—Betamethasone—allergic rhinitis	4.52e-05	0.000358	CcSEcCtD
Celecoxib—Angioedema—Hydrocortisone—allergic rhinitis	4.5e-05	0.000356	CcSEcCtD
Celecoxib—Back pain—Triamcinolone—allergic rhinitis	4.49e-05	0.000355	CcSEcCtD
Celecoxib—PDPK1—GPCR downstream signaling—TAC1—allergic rhinitis	4.48e-05	0.00232	CbGpPWpGaD
Celecoxib—Loss of consciousness—Prednisolone—allergic rhinitis	4.43e-05	0.000351	CcSEcCtD
Celecoxib—Vertigo—Hydrocortisone—allergic rhinitis	4.43e-05	0.00035	CcSEcCtD
Celecoxib—Nausea—Montelukast—allergic rhinitis	4.42e-05	0.00035	CcSEcCtD
Celecoxib—Syncope—Hydrocortisone—allergic rhinitis	4.42e-05	0.00035	CcSEcCtD
Celecoxib—MAPK14—Toll-like Receptor Signaling Pathway—NFKB1—allergic rhinitis	4.41e-05	0.00229	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—HLA-DQB1—allergic rhinitis	4.41e-05	0.00229	CbGpPWpGaD
Celecoxib—Angiopathy—Betamethasone—allergic rhinitis	4.39e-05	0.000347	CcSEcCtD
Celecoxib—Angiopathy—Dexamethasone—allergic rhinitis	4.39e-05	0.000347	CcSEcCtD
Celecoxib—PDPK1—Signaling Pathways—PTGDR2—allergic rhinitis	4.37e-05	0.00226	CbGpPWpGaD
Celecoxib—Hypertension—Prednisolone—allergic rhinitis	4.36e-05	0.000345	CcSEcCtD
Celecoxib—Loss of consciousness—Hydrocortisone—allergic rhinitis	4.33e-05	0.000343	CcSEcCtD
Celecoxib—Arrhythmia—Betamethasone—allergic rhinitis	4.32e-05	0.000342	CcSEcCtD
Celecoxib—Arrhythmia—Dexamethasone—allergic rhinitis	4.32e-05	0.000342	CcSEcCtD
Celecoxib—MAPK14—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—allergic rhinitis	4.29e-05	0.00223	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—HLA-G—allergic rhinitis	4.29e-05	0.00222	CbGpPWpGaD
Celecoxib—Alopecia—Dexamethasone—allergic rhinitis	4.27e-05	0.000338	CcSEcCtD
Celecoxib—Alopecia—Betamethasone—allergic rhinitis	4.27e-05	0.000338	CcSEcCtD
Celecoxib—Hypertension—Hydrocortisone—allergic rhinitis	4.25e-05	0.000337	CcSEcCtD
Celecoxib—Angioedema—Triamcinolone—allergic rhinitis	4.24e-05	0.000335	CcSEcCtD
Celecoxib—Angioedema—Methylprednisolone—allergic rhinitis	4.23e-05	0.000335	CcSEcCtD
Celecoxib—Myalgia—Hydrocortisone—allergic rhinitis	4.2e-05	0.000332	CcSEcCtD
Celecoxib—Anxiety—Hydrocortisone—allergic rhinitis	4.18e-05	0.000331	CcSEcCtD
Celecoxib—Vertigo—Triamcinolone—allergic rhinitis	4.17e-05	0.00033	CcSEcCtD
Celecoxib—PDPK1—GPCR downstream signaling—IL5—allergic rhinitis	4.17e-05	0.00216	CbGpPWpGaD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—allergic rhinitis	4.17e-05	0.00033	CcSEcCtD
Celecoxib—Syncope—Triamcinolone—allergic rhinitis	4.16e-05	0.000329	CcSEcCtD
Celecoxib—Vertigo—Methylprednisolone—allergic rhinitis	4.16e-05	0.000329	CcSEcCtD
Celecoxib—Syncope—Methylprednisolone—allergic rhinitis	4.15e-05	0.000328	CcSEcCtD
Celecoxib—MAPK14—Immune System—MS4A2—allergic rhinitis	4.13e-05	0.00214	CbGpPWpGaD
Celecoxib—Oedema—Prednisolone—allergic rhinitis	4.12e-05	0.000326	CcSEcCtD
Celecoxib—Anaphylactic shock—Prednisolone—allergic rhinitis	4.12e-05	0.000326	CcSEcCtD
Celecoxib—Loss of consciousness—Triamcinolone—allergic rhinitis	4.08e-05	0.000323	CcSEcCtD
Celecoxib—PDPK1—Signaling by GPCR—TAC1—allergic rhinitis	4.07e-05	0.00211	CbGpPWpGaD
Celecoxib—Loss of consciousness—Methylprednisolone—allergic rhinitis	4.07e-05	0.000322	CcSEcCtD
Celecoxib—MAPK14—Activated TLR4 signalling—NFKB1—allergic rhinitis	4.07e-05	0.00211	CbGpPWpGaD
Celecoxib—MAPK14—TCR Signaling Pathway—TGFB1—allergic rhinitis	4.06e-05	0.00211	CbGpPWpGaD
Celecoxib—ALB—Selenium Micronutrient Network—ICAM1—allergic rhinitis	4.05e-05	0.0021	CbGpPWpGaD
Celecoxib—Shock—Prednisolone—allergic rhinitis	4.05e-05	0.000321	CcSEcCtD
Celecoxib—Cough—Triamcinolone—allergic rhinitis	4.05e-05	0.00032	CcSEcCtD
Celecoxib—Anaphylactic shock—Hydrocortisone—allergic rhinitis	4.02e-05	0.000318	CcSEcCtD
Celecoxib—Oedema—Hydrocortisone—allergic rhinitis	4.02e-05	0.000318	CcSEcCtD
Celecoxib—Tachycardia—Prednisolone—allergic rhinitis	4.02e-05	0.000318	CcSEcCtD
Celecoxib—Hypertension—Triamcinolone—allergic rhinitis	4.01e-05	0.000317	CcSEcCtD
Celecoxib—Hypertension—Methylprednisolone—allergic rhinitis	4e-05	0.000316	CcSEcCtD
Celecoxib—Infection—Hydrocortisone—allergic rhinitis	4e-05	0.000316	CcSEcCtD
Celecoxib—MAPK14—Corticotropin-releasing hormone—TGFB1—allergic rhinitis	3.99e-05	0.00207	CbGpPWpGaD
Celecoxib—Hyperhidrosis—Prednisolone—allergic rhinitis	3.98e-05	0.000315	CcSEcCtD
Celecoxib—ALB—Vitamin B12 Metabolism—NFKB1—allergic rhinitis	3.97e-05	0.00206	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—ICAM1—allergic rhinitis	3.96e-05	0.00206	CbGpPWpGaD
Celecoxib—Shock—Hydrocortisone—allergic rhinitis	3.96e-05	0.000313	CcSEcCtD
Celecoxib—Myalgia—Triamcinolone—allergic rhinitis	3.95e-05	0.000313	CcSEcCtD
Celecoxib—Nervous system disorder—Hydrocortisone—allergic rhinitis	3.94e-05	0.000312	CcSEcCtD
Celecoxib—Arthralgia—Methylprednisolone—allergic rhinitis	3.94e-05	0.000312	CcSEcCtD
Celecoxib—Myalgia—Methylprednisolone—allergic rhinitis	3.94e-05	0.000312	CcSEcCtD
Celecoxib—Anxiety—Methylprednisolone—allergic rhinitis	3.93e-05	0.000311	CcSEcCtD
Celecoxib—Tachycardia—Hydrocortisone—allergic rhinitis	3.93e-05	0.000311	CcSEcCtD
Celecoxib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—allergic rhinitis	3.91e-05	0.00031	CcSEcCtD
Celecoxib—ABCC4—Hemostasis—IL5—allergic rhinitis	3.91e-05	0.00203	CbGpPWpGaD
Celecoxib—Skin disorder—Hydrocortisone—allergic rhinitis	3.91e-05	0.000309	CcSEcCtD
Celecoxib—Hyperhidrosis—Hydrocortisone—allergic rhinitis	3.89e-05	0.000308	CcSEcCtD
Celecoxib—Dry mouth—Triamcinolone—allergic rhinitis	3.86e-05	0.000306	CcSEcCtD
Celecoxib—Angioedema—Dexamethasone—allergic rhinitis	3.85e-05	0.000304	CcSEcCtD
Celecoxib—Angioedema—Betamethasone—allergic rhinitis	3.85e-05	0.000304	CcSEcCtD
Celecoxib—Anorexia—Hydrocortisone—allergic rhinitis	3.83e-05	0.000303	CcSEcCtD
Celecoxib—MAPK14—Toll Like Receptor 4 (TLR4) Cascade—NFKB1—allergic rhinitis	3.82e-05	0.00198	CbGpPWpGaD
Celecoxib—PTGS2—C-MYB transcription factor network—CD4—allergic rhinitis	3.82e-05	0.00198	CbGpPWpGaD
Celecoxib—PDPK1—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	3.81e-05	0.00198	CbGpPWpGaD
Celecoxib—Confusional state—Methylprednisolone—allergic rhinitis	3.81e-05	0.000301	CcSEcCtD
Celecoxib—Anaphylactic shock—Triamcinolone—allergic rhinitis	3.79e-05	0.0003	CcSEcCtD
Celecoxib—Oedema—Triamcinolone—allergic rhinitis	3.79e-05	0.0003	CcSEcCtD
Celecoxib—PDPK1—Signaling by GPCR—IL5—allergic rhinitis	3.78e-05	0.00196	CbGpPWpGaD
Celecoxib—Vertigo—Dexamethasone—allergic rhinitis	3.78e-05	0.000299	CcSEcCtD
Celecoxib—Vertigo—Betamethasone—allergic rhinitis	3.78e-05	0.000299	CcSEcCtD
Celecoxib—Anaphylactic shock—Methylprednisolone—allergic rhinitis	3.78e-05	0.000299	CcSEcCtD
Celecoxib—Syncope—Dexamethasone—allergic rhinitis	3.78e-05	0.000299	CcSEcCtD
Celecoxib—Syncope—Betamethasone—allergic rhinitis	3.78e-05	0.000299	CcSEcCtD
Celecoxib—Infection—Triamcinolone—allergic rhinitis	3.76e-05	0.000298	CcSEcCtD
Celecoxib—Infection—Methylprednisolone—allergic rhinitis	3.75e-05	0.000297	CcSEcCtD
Celecoxib—Shock—Triamcinolone—allergic rhinitis	3.73e-05	0.000295	CcSEcCtD
Celecoxib—Insomnia—Prednisolone—allergic rhinitis	3.72e-05	0.000295	CcSEcCtD
Celecoxib—PDPK1—Signaling by NGF—NFKB1—allergic rhinitis	3.72e-05	0.00193	CbGpPWpGaD
Celecoxib—Shock—Methylprednisolone—allergic rhinitis	3.72e-05	0.000294	CcSEcCtD
Celecoxib—Nervous system disorder—Methylprednisolone—allergic rhinitis	3.71e-05	0.000293	CcSEcCtD
Celecoxib—Loss of consciousness—Dexamethasone—allergic rhinitis	3.7e-05	0.000293	CcSEcCtD
Celecoxib—Loss of consciousness—Betamethasone—allergic rhinitis	3.7e-05	0.000293	CcSEcCtD
Celecoxib—Paraesthesia—Prednisolone—allergic rhinitis	3.7e-05	0.000293	CcSEcCtD
Celecoxib—Tachycardia—Triamcinolone—allergic rhinitis	3.7e-05	0.000292	CcSEcCtD
Celecoxib—Tachycardia—Methylprednisolone—allergic rhinitis	3.69e-05	0.000292	CcSEcCtD
Celecoxib—Skin disorder—Methylprednisolone—allergic rhinitis	3.67e-05	0.00029	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Hydrocortisone—allergic rhinitis	3.66e-05	0.00029	CcSEcCtD
Celecoxib—Hyperhidrosis—Triamcinolone—allergic rhinitis	3.66e-05	0.00029	CcSEcCtD
Celecoxib—Hyperhidrosis—Methylprednisolone—allergic rhinitis	3.65e-05	0.000289	CcSEcCtD
Celecoxib—Insomnia—Hydrocortisone—allergic rhinitis	3.64e-05	0.000288	CcSEcCtD
Celecoxib—Hypertension—Dexamethasone—allergic rhinitis	3.63e-05	0.000288	CcSEcCtD
Celecoxib—Hypertension—Betamethasone—allergic rhinitis	3.63e-05	0.000288	CcSEcCtD
Celecoxib—Paraesthesia—Hydrocortisone—allergic rhinitis	3.61e-05	0.000286	CcSEcCtD
Celecoxib—MAPK14—Senescence and Autophagy in Cancer—TGFB1—allergic rhinitis	3.59e-05	0.00186	CbGpPWpGaD
Celecoxib—Myalgia—Dexamethasone—allergic rhinitis	3.58e-05	0.000284	CcSEcCtD
Celecoxib—Myalgia—Betamethasone—allergic rhinitis	3.58e-05	0.000284	CcSEcCtD
Celecoxib—Anxiety—Dexamethasone—allergic rhinitis	3.57e-05	0.000283	CcSEcCtD
Celecoxib—Anxiety—Betamethasone—allergic rhinitis	3.57e-05	0.000283	CcSEcCtD
Celecoxib—Dyspepsia—Hydrocortisone—allergic rhinitis	3.54e-05	0.00028	CcSEcCtD
Celecoxib—Decreased appetite—Hydrocortisone—allergic rhinitis	3.5e-05	0.000277	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Hydrocortisone—allergic rhinitis	3.47e-05	0.000275	CcSEcCtD
Celecoxib—Fatigue—Hydrocortisone—allergic rhinitis	3.47e-05	0.000274	CcSEcCtD
Celecoxib—PDPK1—Immune System—IL5—allergic rhinitis	3.46e-05	0.00179	CbGpPWpGaD
Celecoxib—Musculoskeletal discomfort—Triamcinolone—allergic rhinitis	3.45e-05	0.000273	CcSEcCtD
Celecoxib—MAPK14—Regulation of toll-like receptor signaling pathway—NFKB1—allergic rhinitis	3.45e-05	0.00179	CbGpPWpGaD
Celecoxib—Musculoskeletal discomfort—Methylprednisolone—allergic rhinitis	3.44e-05	0.000272	CcSEcCtD
Celecoxib—Anaphylactic shock—Dexamethasone—allergic rhinitis	3.44e-05	0.000272	CcSEcCtD
Celecoxib—Anaphylactic shock—Betamethasone—allergic rhinitis	3.44e-05	0.000272	CcSEcCtD
Celecoxib—Oedema—Dexamethasone—allergic rhinitis	3.44e-05	0.000272	CcSEcCtD
Celecoxib—Oedema—Betamethasone—allergic rhinitis	3.44e-05	0.000272	CcSEcCtD
Celecoxib—ALB—Platelet activation, signaling and aggregation—IL5—allergic rhinitis	3.44e-05	0.00178	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—CYSLTR1—allergic rhinitis	3.43e-05	0.00178	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—IL5—allergic rhinitis	3.43e-05	0.00178	CbGpPWpGaD
Celecoxib—Insomnia—Triamcinolone—allergic rhinitis	3.42e-05	0.000271	CcSEcCtD
Celecoxib—CA9—Cellular responses to stress—NFKB1—allergic rhinitis	3.42e-05	0.00177	CbGpPWpGaD
Celecoxib—Insomnia—Methylprednisolone—allergic rhinitis	3.42e-05	0.00027	CcSEcCtD
Celecoxib—Infection—Dexamethasone—allergic rhinitis	3.41e-05	0.00027	CcSEcCtD
Celecoxib—Infection—Betamethasone—allergic rhinitis	3.41e-05	0.00027	CcSEcCtD
Celecoxib—MAPK14—Toll-Like Receptors Cascades—NFKB1—allergic rhinitis	3.41e-05	0.00177	CbGpPWpGaD
Celecoxib—Paraesthesia—Triamcinolone—allergic rhinitis	3.4e-05	0.000269	CcSEcCtD
Celecoxib—Feeling abnormal—Prednisolone—allergic rhinitis	3.39e-05	0.000268	CcSEcCtD
Celecoxib—Paraesthesia—Methylprednisolone—allergic rhinitis	3.39e-05	0.000268	CcSEcCtD
Celecoxib—MAPK14—Developmental Biology—ADIPOQ—allergic rhinitis	3.38e-05	0.00175	CbGpPWpGaD
Celecoxib—Shock—Betamethasone—allergic rhinitis	3.38e-05	0.000267	CcSEcCtD
Celecoxib—Shock—Dexamethasone—allergic rhinitis	3.38e-05	0.000267	CcSEcCtD
Celecoxib—Dyspnoea—Triamcinolone—allergic rhinitis	3.38e-05	0.000267	CcSEcCtD
Celecoxib—Nervous system disorder—Betamethasone—allergic rhinitis	3.37e-05	0.000267	CcSEcCtD
Celecoxib—Nervous system disorder—Dexamethasone—allergic rhinitis	3.37e-05	0.000267	CcSEcCtD
Celecoxib—Thrombocytopenia—Dexamethasone—allergic rhinitis	3.36e-05	0.000266	CcSEcCtD
Celecoxib—Thrombocytopenia—Betamethasone—allergic rhinitis	3.36e-05	0.000266	CcSEcCtD
Celecoxib—Tachycardia—Dexamethasone—allergic rhinitis	3.35e-05	0.000265	CcSEcCtD
Celecoxib—Tachycardia—Betamethasone—allergic rhinitis	3.35e-05	0.000265	CcSEcCtD
Celecoxib—MAPK14—BDNF signaling pathway—NFKB1—allergic rhinitis	3.35e-05	0.00174	CbGpPWpGaD
Celecoxib—Dyspepsia—Triamcinolone—allergic rhinitis	3.33e-05	0.000264	CcSEcCtD
Celecoxib—Dyspepsia—Methylprednisolone—allergic rhinitis	3.33e-05	0.000263	CcSEcCtD
Celecoxib—Hyperhidrosis—Betamethasone—allergic rhinitis	3.32e-05	0.000263	CcSEcCtD
Celecoxib—Hyperhidrosis—Dexamethasone—allergic rhinitis	3.32e-05	0.000263	CcSEcCtD
Celecoxib—Feeling abnormal—Hydrocortisone—allergic rhinitis	3.31e-05	0.000262	CcSEcCtD
Celecoxib—PDPK1—Signaling Pathways—CCL11—allergic rhinitis	3.31e-05	0.00172	CbGpPWpGaD
Celecoxib—Gastrointestinal pain—Hydrocortisone—allergic rhinitis	3.29e-05	0.00026	CcSEcCtD
Celecoxib—Anorexia—Dexamethasone—allergic rhinitis	3.28e-05	0.000259	CcSEcCtD
Celecoxib—Anorexia—Betamethasone—allergic rhinitis	3.28e-05	0.000259	CcSEcCtD
Celecoxib—Urticaria—Prednisolone—allergic rhinitis	3.27e-05	0.000259	CcSEcCtD
Celecoxib—Fatigue—Triamcinolone—allergic rhinitis	3.26e-05	0.000258	CcSEcCtD
Celecoxib—Fatigue—Methylprednisolone—allergic rhinitis	3.26e-05	0.000258	CcSEcCtD
Celecoxib—ALB—Folate Metabolism—NFKB1—allergic rhinitis	3.23e-05	0.00168	CbGpPWpGaD
Celecoxib—PDPK1—Adaptive Immune System—ICAM1—allergic rhinitis	3.22e-05	0.00167	CbGpPWpGaD
Celecoxib—Urticaria—Hydrocortisone—allergic rhinitis	3.19e-05	0.000253	CcSEcCtD
Celecoxib—Abdominal pain—Hydrocortisone—allergic rhinitis	3.18e-05	0.000252	CcSEcCtD
Celecoxib—Body temperature increased—Hydrocortisone—allergic rhinitis	3.18e-05	0.000252	CcSEcCtD
Celecoxib—PTGS2—Selenium Micronutrient Network—NFKB1—allergic rhinitis	3.17e-05	0.00165	CbGpPWpGaD
Celecoxib—ABCC4—NRF2 pathway—TGFB1—allergic rhinitis	3.15e-05	0.00163	CbGpPWpGaD
Celecoxib—Musculoskeletal discomfort—Dexamethasone—allergic rhinitis	3.13e-05	0.000248	CcSEcCtD
Celecoxib—Musculoskeletal discomfort—Betamethasone—allergic rhinitis	3.13e-05	0.000248	CcSEcCtD
Celecoxib—Feeling abnormal—Triamcinolone—allergic rhinitis	3.12e-05	0.000247	CcSEcCtD
Celecoxib—Feeling abnormal—Methylprednisolone—allergic rhinitis	3.11e-05	0.000246	CcSEcCtD
Celecoxib—Insomnia—Dexamethasone—allergic rhinitis	3.11e-05	0.000246	CcSEcCtD
Celecoxib—Insomnia—Betamethasone—allergic rhinitis	3.11e-05	0.000246	CcSEcCtD
Celecoxib—Gastrointestinal pain—Methylprednisolone—allergic rhinitis	3.09e-05	0.000244	CcSEcCtD
Celecoxib—Paraesthesia—Dexamethasone—allergic rhinitis	3.09e-05	0.000244	CcSEcCtD
Celecoxib—Paraesthesia—Betamethasone—allergic rhinitis	3.09e-05	0.000244	CcSEcCtD
Celecoxib—Hypersensitivity—Prednisolone—allergic rhinitis	3.03e-05	0.00024	CcSEcCtD
Celecoxib—Dyspepsia—Betamethasone—allergic rhinitis	3.02e-05	0.000239	CcSEcCtD
Celecoxib—Dyspepsia—Dexamethasone—allergic rhinitis	3.02e-05	0.000239	CcSEcCtD
Celecoxib—Urticaria—Triamcinolone—allergic rhinitis	3.01e-05	0.000238	CcSEcCtD
Celecoxib—Urticaria—Methylprednisolone—allergic rhinitis	3e-05	0.000237	CcSEcCtD
Celecoxib—Body temperature increased—Triamcinolone—allergic rhinitis	2.99e-05	0.000237	CcSEcCtD
Celecoxib—MAPK14—TGF-beta Signaling Pathway—TGFB1—allergic rhinitis	2.99e-05	0.00155	CbGpPWpGaD
Celecoxib—Abdominal pain—Methylprednisolone—allergic rhinitis	2.99e-05	0.000236	CcSEcCtD
Celecoxib—Decreased appetite—Betamethasone—allergic rhinitis	2.99e-05	0.000236	CcSEcCtD
Celecoxib—Decreased appetite—Dexamethasone—allergic rhinitis	2.99e-05	0.000236	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Dexamethasone—allergic rhinitis	2.97e-05	0.000235	CcSEcCtD
Celecoxib—Gastrointestinal disorder—Betamethasone—allergic rhinitis	2.97e-05	0.000235	CcSEcCtD
Celecoxib—Hypersensitivity—Hydrocortisone—allergic rhinitis	2.96e-05	0.000234	CcSEcCtD
Celecoxib—Fatigue—Betamethasone—allergic rhinitis	2.96e-05	0.000234	CcSEcCtD
Celecoxib—Fatigue—Dexamethasone—allergic rhinitis	2.96e-05	0.000234	CcSEcCtD
Celecoxib—MAPK14—MAPK Signaling Pathway—NFKB1—allergic rhinitis	2.96e-05	0.00154	CbGpPWpGaD
Celecoxib—Asthenia—Hydrocortisone—allergic rhinitis	2.89e-05	0.000228	CcSEcCtD
Celecoxib—Pruritus—Hydrocortisone—allergic rhinitis	2.85e-05	0.000225	CcSEcCtD
Celecoxib—Feeling abnormal—Dexamethasone—allergic rhinitis	2.83e-05	0.000224	CcSEcCtD
Celecoxib—Feeling abnormal—Betamethasone—allergic rhinitis	2.83e-05	0.000224	CcSEcCtD
Celecoxib—Gastrointestinal pain—Dexamethasone—allergic rhinitis	2.81e-05	0.000222	CcSEcCtD
Celecoxib—Gastrointestinal pain—Betamethasone—allergic rhinitis	2.81e-05	0.000222	CcSEcCtD
Celecoxib—Hypersensitivity—Triamcinolone—allergic rhinitis	2.79e-05	0.000221	CcSEcCtD
Celecoxib—Hypersensitivity—Methylprednisolone—allergic rhinitis	2.78e-05	0.00022	CcSEcCtD
Celecoxib—Diarrhoea—Hydrocortisone—allergic rhinitis	2.75e-05	0.000218	CcSEcCtD
Celecoxib—MAPK14—Cellular Senescence—NFKB1—allergic rhinitis	2.73e-05	0.00142	CbGpPWpGaD
Celecoxib—Urticaria—Betamethasone—allergic rhinitis	2.73e-05	0.000216	CcSEcCtD
Celecoxib—Urticaria—Dexamethasone—allergic rhinitis	2.73e-05	0.000216	CcSEcCtD
Celecoxib—Dizziness—Prednisolone—allergic rhinitis	2.72e-05	0.000215	CcSEcCtD
Celecoxib—Asthenia—Triamcinolone—allergic rhinitis	2.72e-05	0.000215	CcSEcCtD
Celecoxib—Abdominal pain—Dexamethasone—allergic rhinitis	2.72e-05	0.000215	CcSEcCtD
Celecoxib—Abdominal pain—Betamethasone—allergic rhinitis	2.72e-05	0.000215	CcSEcCtD
Celecoxib—Body temperature increased—Dexamethasone—allergic rhinitis	2.72e-05	0.000215	CcSEcCtD
Celecoxib—Body temperature increased—Betamethasone—allergic rhinitis	2.72e-05	0.000215	CcSEcCtD
Celecoxib—Asthenia—Methylprednisolone—allergic rhinitis	2.71e-05	0.000214	CcSEcCtD
Celecoxib—Pruritus—Triamcinolone—allergic rhinitis	2.68e-05	0.000212	CcSEcCtD
Celecoxib—PDPK1—Immune System—HLA-DQB1—allergic rhinitis	2.68e-05	0.00139	CbGpPWpGaD
Celecoxib—Pruritus—Methylprednisolone—allergic rhinitis	2.67e-05	0.000211	CcSEcCtD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	2.67e-05	0.00139	CbGpPWpGaD
Celecoxib—Dizziness—Hydrocortisone—allergic rhinitis	2.66e-05	0.00021	CcSEcCtD
Celecoxib—Rash—Prednisolone—allergic rhinitis	2.6e-05	0.000205	CcSEcCtD
Celecoxib—Dermatitis—Prednisolone—allergic rhinitis	2.59e-05	0.000205	CcSEcCtD
Celecoxib—Diarrhoea—Methylprednisolone—allergic rhinitis	2.59e-05	0.000205	CcSEcCtD
Celecoxib—Headache—Prednisolone—allergic rhinitis	2.58e-05	0.000204	CcSEcCtD
Celecoxib—ALB—Selenium Micronutrient Network—NFKB1—allergic rhinitis	2.57e-05	0.00133	CbGpPWpGaD
Celecoxib—Vomiting—Hydrocortisone—allergic rhinitis	2.56e-05	0.000202	CcSEcCtD
Celecoxib—Rash—Hydrocortisone—allergic rhinitis	2.54e-05	0.000201	CcSEcCtD
Celecoxib—Dermatitis—Hydrocortisone—allergic rhinitis	2.53e-05	0.0002	CcSEcCtD
Celecoxib—Headache—Hydrocortisone—allergic rhinitis	2.52e-05	0.000199	CcSEcCtD
Celecoxib—Dizziness—Triamcinolone—allergic rhinitis	2.5e-05	0.000198	CcSEcCtD
Celecoxib—Dizziness—Methylprednisolone—allergic rhinitis	2.5e-05	0.000198	CcSEcCtD
Celecoxib—MAPK14—MAPK Signaling Pathway—TGFB1—allergic rhinitis	2.47e-05	0.00128	CbGpPWpGaD
Celecoxib—Asthenia—Dexamethasone—allergic rhinitis	2.47e-05	0.000195	CcSEcCtD
Celecoxib—Asthenia—Betamethasone—allergic rhinitis	2.47e-05	0.000195	CcSEcCtD
Celecoxib—PDPK1—Innate Immune System—CD4—allergic rhinitis	2.46e-05	0.00128	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—SMAD3—allergic rhinitis	2.46e-05	0.00127	CbGpPWpGaD
Celecoxib—Nausea—Prednisolone—allergic rhinitis	2.45e-05	0.000194	CcSEcCtD
Celecoxib—Pruritus—Dexamethasone—allergic rhinitis	2.43e-05	0.000192	CcSEcCtD
Celecoxib—Pruritus—Betamethasone—allergic rhinitis	2.43e-05	0.000192	CcSEcCtD
Celecoxib—Vomiting—Triamcinolone—allergic rhinitis	2.41e-05	0.00019	CcSEcCtD
Celecoxib—PDPK1—Signaling Pathways—TAC1—allergic rhinitis	2.4e-05	0.00125	CbGpPWpGaD
Celecoxib—Vomiting—Methylprednisolone—allergic rhinitis	2.4e-05	0.00019	CcSEcCtD
Celecoxib—Nausea—Hydrocortisone—allergic rhinitis	2.39e-05	0.000189	CcSEcCtD
Celecoxib—Rash—Triamcinolone—allergic rhinitis	2.39e-05	0.000189	CcSEcCtD
Celecoxib—Dermatitis—Triamcinolone—allergic rhinitis	2.39e-05	0.000189	CcSEcCtD
Celecoxib—Rash—Methylprednisolone—allergic rhinitis	2.38e-05	0.000188	CcSEcCtD
Celecoxib—Dermatitis—Methylprednisolone—allergic rhinitis	2.38e-05	0.000188	CcSEcCtD
Celecoxib—Headache—Triamcinolone—allergic rhinitis	2.37e-05	0.000188	CcSEcCtD
Celecoxib—Headache—Methylprednisolone—allergic rhinitis	2.37e-05	0.000187	CcSEcCtD
Celecoxib—PDPK1—Adaptive Immune System—CD4—allergic rhinitis	2.37e-05	0.00123	CbGpPWpGaD
Celecoxib—Diarrhoea—Betamethasone—allergic rhinitis	2.35e-05	0.000186	CcSEcCtD
Celecoxib—Diarrhoea—Dexamethasone—allergic rhinitis	2.35e-05	0.000186	CcSEcCtD
Celecoxib—ALB—Platelet degranulation—TGFB1—allergic rhinitis	2.31e-05	0.0012	CbGpPWpGaD
Celecoxib—Dizziness—Dexamethasone—allergic rhinitis	2.27e-05	0.00018	CcSEcCtD
Celecoxib—Dizziness—Betamethasone—allergic rhinitis	2.27e-05	0.00018	CcSEcCtD
Celecoxib—MAPK14—Signaling Pathways—PTGDR2—allergic rhinitis	2.27e-05	0.00118	CbGpPWpGaD
Celecoxib—ABCC4—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	2.26e-05	0.00117	CbGpPWpGaD
Celecoxib—Nausea—Triamcinolone—allergic rhinitis	2.25e-05	0.000178	CcSEcCtD
Celecoxib—PDPK1—Disease—SMAD3—allergic rhinitis	2.25e-05	0.00116	CbGpPWpGaD
Celecoxib—Nausea—Methylprednisolone—allergic rhinitis	2.24e-05	0.000178	CcSEcCtD
Celecoxib—PDPK1—Signaling Pathways—IL5—allergic rhinitis	2.24e-05	0.00116	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-G—allergic rhinitis	2.23e-05	0.00116	CbGpPWpGaD
Celecoxib—MAPK14—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	2.23e-05	0.00115	CbGpPWpGaD
Celecoxib—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—allergic rhinitis	2.2e-05	0.00114	CbGpPWpGaD
Celecoxib—Vomiting—Betamethasone—allergic rhinitis	2.18e-05	0.000173	CcSEcCtD
Celecoxib—Vomiting—Dexamethasone—allergic rhinitis	2.18e-05	0.000173	CcSEcCtD
Celecoxib—Rash—Dexamethasone—allergic rhinitis	2.17e-05	0.000171	CcSEcCtD
Celecoxib—Rash—Betamethasone—allergic rhinitis	2.17e-05	0.000171	CcSEcCtD
Celecoxib—Dermatitis—Betamethasone—allergic rhinitis	2.16e-05	0.000171	CcSEcCtD
Celecoxib—Dermatitis—Dexamethasone—allergic rhinitis	2.16e-05	0.000171	CcSEcCtD
Celecoxib—Headache—Dexamethasone—allergic rhinitis	2.15e-05	0.00017	CcSEcCtD
Celecoxib—Headache—Betamethasone—allergic rhinitis	2.15e-05	0.00017	CcSEcCtD
Celecoxib—PDPK1—Innate Immune System—NFKB1—allergic rhinitis	2.12e-05	0.0011	CbGpPWpGaD
Celecoxib—PTGS2—Spinal Cord Injury—TGFB1—allergic rhinitis	2.09e-05	0.00108	CbGpPWpGaD
Celecoxib—MAPK14—Cellular responses to stress—NFKB1—allergic rhinitis	2.06e-05	0.00107	CbGpPWpGaD
Celecoxib—Nausea—Betamethasone—allergic rhinitis	2.04e-05	0.000161	CcSEcCtD
Celecoxib—Nausea—Dexamethasone—allergic rhinitis	2.04e-05	0.000161	CcSEcCtD
Celecoxib—PDPK1—Adaptive Immune System—NFKB1—allergic rhinitis	2.04e-05	0.00106	CbGpPWpGaD
Celecoxib—MAPK14—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	1.98e-05	0.00103	CbGpPWpGaD
Celecoxib—PDPK1—Hemostasis—TGFB1—allergic rhinitis	1.96e-05	0.00102	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—ICAM1—allergic rhinitis	1.95e-05	0.00101	CbGpPWpGaD
Celecoxib—MAPK14—Signaling by NGF—NFKB1—allergic rhinitis	1.93e-05	0.001	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—IL5—allergic rhinitis	1.8e-05	0.000932	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CYSLTR1—allergic rhinitis	1.78e-05	0.000923	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—IL5—allergic rhinitis	1.77e-05	0.000918	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—CCL11—allergic rhinitis	1.72e-05	0.000892	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—allergic rhinitis	1.71e-05	0.000885	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—SMAD3—allergic rhinitis	1.57e-05	0.000816	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—CD4—allergic rhinitis	1.44e-05	0.000744	CbGpPWpGaD
Celecoxib—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—allergic rhinitis	1.42e-05	0.000737	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—HLA-DQB1—allergic rhinitis	1.39e-05	0.000721	CbGpPWpGaD
Celecoxib—PDPK1—Disease—CD4—allergic rhinitis	1.33e-05	0.000687	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—CD4—allergic rhinitis	1.28e-05	0.000664	CbGpPWpGaD
Celecoxib—MAPK14—Gene Expression—SMAD3—allergic rhinitis	1.26e-05	0.000652	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—NFKB1—allergic rhinitis	1.25e-05	0.000648	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TAC1—allergic rhinitis	1.25e-05	0.000648	CbGpPWpGaD
Celecoxib—PDPK1—Immune System—NFKB1—allergic rhinitis	1.24e-05	0.000641	CbGpPWpGaD
Celecoxib—ABCC4—Hemostasis—TGFB1—allergic rhinitis	1.17e-05	0.000605	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—IL5—allergic rhinitis	1.16e-05	0.000602	CbGpPWpGaD
Celecoxib—MAPK14—Innate Immune System—NFKB1—allergic rhinitis	1.1e-05	0.000572	CbGpPWpGaD
Celecoxib—MAPK14—Developmental Biology—TGFB1—allergic rhinitis	1.04e-05	0.00054	CbGpPWpGaD
Celecoxib—ALB—Platelet activation, signaling and aggregation—TGFB1—allergic rhinitis	1.02e-05	0.000531	CbGpPWpGaD
Celecoxib—MAPK14—Hemostasis—TGFB1—allergic rhinitis	1.02e-05	0.000529	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—ICAM1—allergic rhinitis	1.02e-05	0.000526	CbGpPWpGaD
Celecoxib—PDPK1—Disease—TGFB1—allergic rhinitis	9.51e-06	0.000493	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—SMAD3—allergic rhinitis	8.18e-06	0.000424	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—NFKB1—allergic rhinitis	8e-06	0.000415	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—CD4—allergic rhinitis	7.46e-06	0.000387	CbGpPWpGaD
Celecoxib—PTGS2—Disease—SMAD3—allergic rhinitis	7.46e-06	0.000387	CbGpPWpGaD
Celecoxib—PDPK1—Signaling Pathways—TGFB1—allergic rhinitis	6.66e-06	0.000345	CbGpPWpGaD
Celecoxib—MAPK14—Immune System—NFKB1—allergic rhinitis	6.43e-06	0.000333	CbGpPWpGaD
Celecoxib—ALB—Hemostasis—TGFB1—allergic rhinitis	5.28e-06	0.000274	CbGpPWpGaD
Celecoxib—PTGS2—Disease—CD4—allergic rhinitis	4.4e-06	0.000228	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—NFKB1—allergic rhinitis	4.16e-06	0.000215	CbGpPWpGaD
Celecoxib—MAPK14—Signaling Pathways—TGFB1—allergic rhinitis	3.46e-06	0.000179	CbGpPWpGaD
Celecoxib—PTGS2—Disease—TGFB1—allergic rhinitis	3.16e-06	0.000164	CbGpPWpGaD
